Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001642247-17-000004

CEO bought 20,000 shares at $0.53 ($10,600)

From the SEC's structured data for this filing

Trades in this filing

LAVOY THOMAS C · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-03-10 Purchase : show line 1 in the form +20,000 $0.53 $10,600 183,523 D
Open-market purchases · 20,000 sh · avg $0.53 · $10,600
Loading xslF345X03/primary_doc.xml…